Dr Ariel Beresniak took part in the Ethics Prize Seminar in Stockholm in October 2016, where he discussed once again how inadequate, inaccurate and unethical the QALY approach is when used for making a decision about new medicines’ access to patients in need.
This seminar was organised by the Swedish Council of Medical Ethics.
The full seminar broadcast can be viewed here. Dr Ariel Beresniak’s presentation starts at 1:50:13.
More information on the QALYs and DMI’s role in the ECHOUTCOME project: www.echoutcome.eu.